Skip to content

Clinical Study on Treatment of Post-stroke Sleep Disorders with Xingnao Kaiqiao Acupuncture

Clinical Study on Treatment of Post-stroke Sleep Disorders with Xingnao Kaiqiao Acupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012477
Enrollment
Unknown
Registered
2017-07-24
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Sleep Disorders

Interventions

Acupuncture group:Xingnao Kaiqiao Acupuncture+Yangxue Rougan Acupuncture+Basic treatment+Placebo (estazolam tablets)
Control group:Conventional acupuncture treatment+Basic treatment+Estazolam tablets

Sponsors

Tianjin Academy of Traditional Chinese Medcine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Individuals who meet the diagnostic criteria of stroke and sleep disorders; 2. Individuals who suffered first stroke, and no sleep disorder, no obvious intelligence, language understanding and expression barrier before onset of stroke, and can basically complete various scale evaluation; 3. Individuals between the ages of 45 and 80 years; 4. The Pittsburgh Sleep Quality Index(PSQI) scored more than seven points; 5. Individuals between 15 to 180 days after onset of stroke; 6. Individuals who less than six hours of night sleep, and frequent awakening or sleepless nights after stroke, and last more than three times a week for more than a month; 7. Individuals who voluntarily agree with a study protocol and sign a written informed consent; Individuals, who meet the both above seven criteria, were selected.

Exclusion criteria

Exclusion criteria: 1. Individuals who not conforming to the diagnosis and inclusion criteria; 2. Individuals were allergic to estazolam; 3. Patients with vascular dementia and severe aphasia were not able to carry out the questionnaire; 4. Sleep disorders caused by drugs or alcohol. Alcoholism or drug dependence (such as long-term treatment of antipsychotic drugs, etc.); 5. Severe mental symptoms. Sleep disorders caused by physical or other mental illness; 6. Other clinical drug researches participated in the past one month, or mental sedatives used in two weeks; 7. Individuals who have severe diseases, such as severe heart, liver(ALT, AST is 50% above the normal limit), kidney(the BUN exceeds the normal limit of 20%, and the Cr exceeds the normal limit range), hematopoietic system and metabolic system, or severe other systerm diseases; 8. Pregnancy, planning a pregnancy or breast-feeding; 9. The use of drugs or treatments that prohibit, or refusal to continue to participate in the test; If one of the above-mentioned items is met, individuals who will be excluded.

Design outcomes

Primary

MeasureTime frame
Sleep rate;Pittsburgh Sleep Quality Index,PSQI;TCM Symptom Scale;Inflammatory factors IL-6;Inflammatory factors IL-8;Inflammatory factors TNF-a;

Secondary

MeasureTime frame
blood routine;urine routine;stool routine;Liver Function(aspartate transaminase,AST;alanine aminotransferase,ALT);Renal Function(blood urea nitrogen,BUN;serum creatinine,Cr);NIH Stroke Scale(NHISS);Activities of Daily Living Scale(ADL);

Countries

China

Contacts

Public ContactZhang Zhilong

Tianjin Academy of Traditional Chinese Medcine Affiliated Hospital

zhangzhilongtj@163.com+86 18222235269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026